ResearcherMoffitt Cancer CenterActive in the last 2 years
Dae Won Kim
Matched on ORCID iD 0000-0003-2151-2841; OpenAlex author ID A5101615432. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 36
2021: 1 paper · 2022: 3 papers · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers
Papers 8
- Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy. Last author DOI 10.3390/cancers17111797↗
- Influence of Coping, Esteem, and Resilience on Caregiver Distress in Pancreatic Cancer Patient-Caregiver Dyads. Co-author DOI 10.3390/healthcare13020114↗
- Stereotactic body radiotherapy plus rucosopasem in locally advanced or borderline resectable pancreatic cancer: GRECO-2 phase II study design. Co-author DOI 10.2217/fon-2022-1219↗
- Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic R… Co-author DOI 10.1177/10732748221150228↗
- A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and be… Co-author DOI 10.1002/cam4.4768↗
- Patient-caregiver dyads in pancreatic cancer: identification of patient and caregiver factors associated with caregiver well-being. Co-author DOI 10.1007/s10865-022-00354-x↗
- Hospital Surgical Volume Is Poorly Correlated With Delivery of Multimodal Treatment for Localized Pancreatic Cancer: A National Retrospective Cohort Study. Co-author DOI 10.1097/as9.0000000000000197↗
- Minimally invasive image-guided therapy of primary and metastatic pancreatic cancer. First author DOI 10.3748/wjg.v27.i27.4322↗
Closest collaborators
The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mokenge Peter Malafa · 6 shared papers, 2021–2025 · strength 0.99
- Paper Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma… DOI 10.3390/cancers17111797↗
- Paper Minimally invasive image-guided therapy of primary and metastatic pancreatic cancer. DOI 10.3748/wjg.v27.i27.4322↗
- Paper Stereotactic body radiotherapy plus rucosopasem in locally advanced or borderline resectable pancreatic cancer: GRECO-2… DOI 10.2217/fon-2022-1219↗
- Pamela Joy Hodul · 5 shared papers, 2022–2025 · strength 0.87
- Paper Influence of Coping, Esteem, and Resilience on Caregiver Distress in Pancreatic Cancer Patient-Caregiver Dyads. DOI 10.3390/healthcare13020114↗
- Paper Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma… DOI 10.3390/cancers17111797↗
- Paper Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-F… DOI 10.1177/10732748221150228↗
- Jason W. Denbo · 4 shared papers, 2022–2025 · strength 0.61
- Paper Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma… DOI 10.3390/cancers17111797↗
- Paper Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-F… DOI 10.1177/10732748221150228↗
- Paper Patient-caregiver dyads in pancreatic cancer: identification of patient and caregiver factors associated with caregiver… DOI 10.1007/s10865-022-00354-x↗
- Jason B. Fleming · 4 shared papers, 2022–2025 · strength 0.61
- Paper Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma… DOI 10.3390/cancers17111797↗
- Paper Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-F… DOI 10.1177/10732748221150228↗
- Paper Patient-caregiver dyads in pancreatic cancer: identification of patient and caregiver factors associated with caregiver… DOI 10.1007/s10865-022-00354-x↗
- Sarah E. Hoffe · 3 shared papers, 2023–2025 · strength 0.53
- Paper Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma… DOI 10.3390/cancers17111797↗
- Paper Stereotactic body radiotherapy plus rucosopasem in locally advanced or borderline resectable pancreatic cancer: GRECO-2… DOI 10.2217/fon-2022-1219↗
- Paper Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-F… DOI 10.1177/10732748221150228↗
- Jennifer B. Permuth · 3 shared papers, 2022–2025 · strength 0.53
- Paper Influence of Coping, Esteem, and Resilience on Caregiver Distress in Pancreatic Cancer Patient-Caregiver Dyads. DOI 10.3390/healthcare13020114↗
- Paper Patient-caregiver dyads in pancreatic cancer: identification of patient and caregiver factors associated with caregiver… DOI 10.1007/s10865-022-00354-x↗
- Paper Hospital Surgical Volume Is Poorly Correlated With Delivery of Multimodal Treatment for Localized Pancreatic Cancer: A … DOI 10.1097/as9.0000000000000197↗
- Nicole Nardella · 2 shared papers, 2025 · strength 0.45
- Paper Influence of Coping, Esteem, and Resilience on Caregiver Distress in Pancreatic Cancer Patient-Caregiver Dyads. DOI 10.3390/healthcare13020114↗
- Paper Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma… DOI 10.3390/cancers17111797↗
- Kelvin Allenson · 2 shared papers, 2022–2025 · strength 0.39
- Paper Influence of Coping, Esteem, and Resilience on Caregiver Distress in Pancreatic Cancer Patient-Caregiver Dyads. DOI 10.3390/healthcare13020114↗
- Paper Patient-caregiver dyads in pancreatic cancer: identification of patient and caregiver factors associated with caregiver… DOI 10.1007/s10865-022-00354-x↗
- Brent Taiting Xia · 2 shared papers, 2022–2025 · strength 0.39
- Paper Influence of Coping, Esteem, and Resilience on Caregiver Distress in Pancreatic Cancer Patient-Caregiver Dyads. DOI 10.3390/healthcare13020114↗
- Paper Patient-caregiver dyads in pancreatic cancer: identification of patient and caregiver factors associated with caregiver… DOI 10.1007/s10865-022-00354-x↗
- Jessica M. Frakes · 2 shared papers, 2023–2025 · strength 0.34
- Paper Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma… DOI 10.3390/cancers17111797↗
- Paper Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-F… DOI 10.1177/10732748221150228↗
- José M. Pimiento · 2 shared papers, 2022–2025 · strength 0.33
- Paper Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma… DOI 10.3390/cancers17111797↗
- Paper Hospital Surgical Volume Is Poorly Correlated With Delivery of Multimodal Treatment for Localized Pancreatic Cancer: A … DOI 10.1097/as9.0000000000000197↗
- James B. Yu · 1 shared paper, 2025 · strength 0.20
- Robin Park · 1 shared paper, 2025 · strength 0.20
- Richard D. Kim · 1 shared paper, 2025 · strength 0.20
- Béla Kis · 1 shared paper, 2021 · strength 0.19
- András Bibok · 1 shared paper, 2021 · strength 0.19
- Michael R. Kurman · 1 shared paper, 2024 · strength 0.19
- Todd Anthony Aguilera · 1 shared paper, 2024 · strength 0.19
- Maged Mofied Ghaly · 1 shared paper, 2024 · strength 0.19
- Joseph M. Herman · 1 shared paper, 2024 · strength 0.19
- Parag Jitendra Parikh · 1 shared paper, 2024 · strength 0.19
- Joseph Michael Caster · 1 shared paper, 2024 · strength 0.19
- Michael David Chuong · 1 shared paper, 2023 · strength 0.14
- John Michael Bryant · 1 shared paper, 2023 · strength 0.14
- Russell F. Palm · 1 shared paper, 2023 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.